Penetrium Bioscience voting rights stake unchanged at 37.57% after pledge contract revision filing

Bitget2026/10/14 08:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Hyundai Bioscience filed an amended large-shareholding report in Penetrium, keeping its voting stake at 24,030,335 shares, or 37.57%.
The update reflected a change in share-pledge arrangements, cutting shares under key contracts to 12,850,000 from 13,070,000.
The disclosure was dated Oct. 14, 2026, with the obligation-trigger date listed as Sept. 21, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Penetrium Bioscience Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014000371), on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Penetrium Bioscience voting rights stake unchanged at 37.57% after pledge contract revision filing

You may also like

Crypto prices